Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-01-03 Sale |
2025-01-07 8:05 pm |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
2,550 | $16.78 | $42,783 | 53,490 (Direct) |
View |
2024-11-14 Sale |
2024-11-18 7:23 pm |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
52,115 | $16.79 | $875,042 | 222,869 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-10 Exercise |
2025-01-13 4:09 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
9,000 | $3.23 | 129,922 (Direct) |
View |
2025-01-10 Exercise |
2025-01-13 4:09 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
9,000 | $0 | 129,922 (Direct) |
View |
2025-01-02 Option Award |
2025-01-06 4:21 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
63,500 | $0 | 103,440 (Direct) |
View |
2024-11-20 Exercise |
2024-11-21 6:50 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
14,000 | $3.23 | 116,372 (Direct) |
View |
2024-11-20 Exercise |
2024-11-21 6:50 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
14,000 | $0 | 116,372 (Direct) |
View |
2024-11-14 Exercise |
2024-11-18 7:23 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
52,115 | $3.23 | 222,869 (Direct) |
View |
2024-11-14 Exercise |
2024-11-18 7:23 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
52,115 | $0 | 222,869 (Direct) |
View |
2024-04-08 Exercise |
2024-04-10 9:35 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
146,823 | $0 | 201,752 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 5:08 pm |
N/A 2034-01-01 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
1,776,200 | $0 | 1,776,200 (Direct) |
View |
2023-11-13 Option Award |
2023-11-15 4:42 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
4,276 | $0 | 4,276 (Direct) |
View |